Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Dow
Argus Health
Accenture
Mallinckrodt
Boehringer Ingelheim
Julphar
Fish and Richardson
Federal Trade Commission
Cerilliant

Generated: December 11, 2017

DrugPatentWatch Database Preview

Details for Patent: 9,011,905

« Back to Dashboard

Which drugs does patent 9,011,905 protect, and when does it expire?


Patent 9,011,905 protects QSYMIA and is included in one NDA. There has been one Paragraph IV challenge on Qsymia.

This patent has thirty-three patent family members in fifteen countries.

Summary for Patent: 9,011,905

Title:Low dose topiramate/phentermine composition and methods of use thereof
Abstract: A method for effecting weight loss by administering a combination of topiramate and phentermine is provided. The phentermine is generally administered in immediate release form, in a daily dose in the range of 2 mg to 8 mg, in combination with a daily dose of topiramate selected to prevent the loss of effectiveness of phentermine alone. Methods for treating obesity, conditions associated with obesity, and other indications are also provided, as are compositions and dosage forms containing low doses of phentermine and topiramate, e.g., 3.75 mg phentermine and 23 mg topiramate.
Inventor(s): Najarian; Thomas (Los Osos, CA), Tam; Peter Y. (Redwood City, CA), Wilson; Leland F. (Menlo Park, CA)
Assignee: Vivus, Inc. (Mountain View, CA)
Application Number:14/495,246
Patent Claim Types:
see list of patent claims
Formulation; Dosage form; Composition;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
VivusQSYMIAphentermine hydrochloride; topiramateCAPSULE, EXTENDED RELEASE;ORAL022580-001Jul 17, 2012RXYesNo► Subscribe► Subscribe► SubscribeY
VivusQSYMIAphentermine hydrochloride; topiramateCAPSULE, EXTENDED RELEASE;ORAL022580-002Jul 17, 2012RXYesNo► Subscribe► Subscribe► SubscribeY
VivusQSYMIAphentermine hydrochloride; topiramateCAPSULE, EXTENDED RELEASE;ORAL022580-003Jul 17, 2012RXYesNo► Subscribe► Subscribe► SubscribeY
VivusQSYMIAphentermine hydrochloride; topiramateCAPSULE, EXTENDED RELEASE;ORAL022580-004Jul 17, 2012RXYesYes► Subscribe► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Patent: 9,011,905

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,580,298Low dose topiramate/phentermine composition and methods of use thereof► Subscribe
8,895,058Low dose topiramate/phentermine composition and methods of use thereof► Subscribe
9,011,906Escalating dosing regimen for effecting weight loss and treating obesity► Subscribe
8,895,057Escalating dosing regimen for effecting weight loss and treating obesity► Subscribe
8,580,299Escalating dosing regimen for effecting weight loss and treating obesity► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 9,011,905

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Israel209874► Subscribe
Canada2727319► Subscribe
China102112126► Subscribe
China102112127► Subscribe
China104825477► Subscribe
China105534921► Subscribe
Cyprus1118103► Subscribe
South Korea20140121491► Subscribe
Japan6077053► Subscribe
Japan2011522896► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Chubb
Citi
Fuji
Express Scripts
Accenture
Cerilliant
Merck
Queensland Health
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot